{"id":"W2978063795","doi":"10.1093/annonc/mdz246.030","title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; Regional Municipality of Durham; University of Ottawa; Lakeridge Health","funders":"","keywords":"Medicine; Bevacizumab; Oxaliplatin; Hazard ratio; Internal medicine; Surgery; Colorectal cancer; Chemotherapy; Perforation; Clinical endpoint; Gastroenterology; Stage (stratigraphy); Randomized controlled trial; Oncology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003571863,0.001046465,0.002704549,0.0004052752,0.0002010693,0.001195436,0.0005973499,0.000752461,0.00226143],"category_scores_gemma":[0.003630089,0.0003772927,0.003130741,0.0006681876,0.0004279246,0.0009653916,0.0005000791,0.002293612,0.000299411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006836284,"about_ca_system_score_gemma":0.000982109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001605059,"about_ca_topic_score_gemma":0.006899319,"domain_scores_codex":[0.9986762,0.0008643476,0.0000763435,0.0001608091,0.0001116792,0.0001105713],"domain_scores_gemma":[0.9981293,0.0007070584,0.000541507,0.0001862112,0.0001377175,0.0002982641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8720985,0.001396508,0.009735058,0.002739371,0.01411927,0.00006735995,0.0001084275,0.00161617,0.003931605,0.000375683,0.006401444,0.08741065],"study_design_scores_gemma":[0.8871617,0.03824008,0.0376245,0.0005736399,0.02490665,0.0001860628,0.00008968318,0.001220824,0.0008852206,0.0009955931,0.008050446,0.00006569426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9222219,0.06032863,0.001989615,0.002175332,0.001431446,0.001754556,0.005489304,0.0001507555,0.004458389],"genre_scores_gemma":[0.961315,0.01793792,0.00405449,0.002951215,0.000816169,0.001408383,0.008333308,0.0001139069,0.003069612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003571863,"threshold_uncertainty_score":0.01889008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05770164256582759,"score_gpt":0.4154097621979003,"score_spread":0.3577081196320727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}